DMAC icon

DiaMedica Therapeutics
DMAC

Overview Fund Activity

32 hedge funds and large institutions have $15.1M invested in DiaMedica Therapeutics in 2023 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
+7
Holders Change %
+28%
% of All Funds
0.5%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
9
Increased
7
Reduced
6
Closed
2
Calls
$127K
Puts
$1K
Net Calls
+$126K
Net Calls Change
+$113K

Top Buyers

1
PAPAIJV
1
Paragon Associates & Paragon Associates II Joint Venture
Texas
$1.4M
2
BL
2
Bleichroeder LP
New York
$1.27M
3
EI
3
EAM Investors
California
$1.17M
4
First Manhattan
4
First Manhattan
New York
$539K
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$73.1K

Top Sellers

1
JAMONY
1
Jacob Asset Management of New York
California
$859K
2
Citadel Advisors
2
Citadel Advisors
Florida
$34.2K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$0
4
Northern Trust
4
Northern Trust
Illinois
$355K
5
UBS Group
5
UBS Group
Switzerland
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
FDCDDQ
26
Federation des caisses Desjardins du Quebec
Quebec, Canada
$994 – – –
Wells Fargo
27
Wells Fargo
California
$501 +$17 +4 +4%
S
28
SignatureFD
Georgia
$108 +$108 +25 New
JPMorgan Chase & Co
29
JPMorgan Chase & Co
New York
$91 +$91 +21 New
Osaic Holdings
30
Osaic Holdings
Arizona
$4 +$4 +1 New
Renaissance Technologies
31
Renaissance Technologies
New York
– -$99K -64,508 Closed
UBS Group
32
UBS Group
Switzerland
– -$3.12K -2,038 Closed
1
2